Search This Blog

Thursday, July 2, 2020

FDA OKs emergency use of Centogene COVID-19 molecular diagnostic test

The FDA has issued Emergency Use Authorization (EUA) for Centogene’s (NASDAQ:CNTG) SARS-CoV-2 RT-PCR test.
The company’s SARS-CoV-2 RT-PCR test is intended to be used with samples of the upper respiratory tract (oropharyngeal swabs).

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)